ABT
$62.25
*
0.17
negative
0.27%

*Data as of May 25, 2012   |   ABT After Hours  | Abbott Laboratories | Industry: Consumer Durables | HQ: Illinois, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

 Save stocks for next time
 |  Sponsored

ABT News Headlines

Share |


   


Gen-Probe Remains Neutral - Analyst Blog
5/25/2012 12:44:03 PM - Zacks.com

Gilead Drug Up for European Review - Analyst Blog
5/24/2012 4:41:01 PM - Zacks.com

Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and Church & Dwight - Press Releases
5/23/2012 9:30:01 AM - Zacks.com

RobMarketsBlind's Latest Purchase - Voice of the People
5/22/2012 5:33:01 PM - Zacks.com

Auxilium-Glaxo to Drive Testim Sales - Analyst Blog
5/22/2012 10:30:01 AM - Zacks.com

Abbott Bid For US Approval Of New Use For Humira Is Delayed
5/22/2012 9:20:00 AM - Dow Jones Business News

J&J's Simponi Helps Colitis Patients In Clinical Trial
5/21/2012 2:44:00 PM - Dow Jones Business News

Myriad to Present Cancer Test Study - Analyst Blog
5/17/2012 3:40:39 PM - Zacks.com

Absolute Software Analyst And Investor Day At 9:00 AM ET
5/17/2012 8:02:00 AM - RTT News

Abbott Helps Big Pharma Look Even Worse
5/16/2012 1:11:00 PM - TheStreet

Abbott Laboratories Launches PediaSure SideKicks Clear For Picky Eaters
5/16/2012 9:40:00 AM - RTT News

Panel Votes in Favor of Pfizer Drug - Analyst Blog
5/15/2012 6:07:52 PM - Zacks.com

Resolute Integrity Coronary Stent System Gets European Regulatory Approval
5/15/2012 2:57:00 PM - RTT News

The Zacks Analyst Blog Highlights: Gilead Sciences, Abbott Labs, Alliance Data Systems Corporation, Blue Nile and Bristol-Myers Squibb - Press Releases
5/15/2012 9:07:18 AM - Zacks.com

Good News for Gilead - Analyst Blog
5/14/2012 3:00:01 PM - Zacks.com

Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis - Press Releases
5/14/2012 9:08:33 AM - Zacks.com

Standard Review for Biogen's BG-12 - Analyst Blog
5/11/2012 4:00:01 PM - Zacks.com

FDA Approves Gen-Probe's PANTHER - Analyst Blog
5/11/2012 1:06:58 PM - Zacks.com

Abbott To Present At Deutsche Bank Conference; Webcast At 10:00 AM ET
5/8/2012 9:00:00 AM - RTT News

2nd UPDATE: Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes
5/7/2012 4:29:00 PM - Dow Jones Business News

Stocks Rebound from Early Session Lows to End Mixed
5/7/2012 4:27:00 PM - Knobias

Absolute Software Q3 12 Earnings Conference Call At 5:00 PM ET
5/7/2012 3:03:00 PM - RTT News

UPDATE: Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes
5/7/2012 2:30:00 PM - Dow Jones Business News

CORRECT: Abbott To Pay $1.6 Billion To Settle Depakote Charges
5/7/2012 2:24:00 PM - Dow Jones Business News

Abbott Agrees To Pay $1.6 Bln. In Depakote Settlement
5/7/2012 2:14:00 PM - RTT News